Observation on Efficacy of Puerarin in Treating Diabetic Retinopathy

Objective: Using the principle of promoting blood circulation to remove s tasis to observe central retinal arterial and venous blood flow indexes, and hemorrheology of diabetic retinopathy patients with puerarin. Methods: Thirty patients with diabetic retinopathy were randomly divided into the treated group (n=15) and the control group (n=15). The treated group was given puerarin 400 mg per day intravenously dripping. The control group was given Mikebao 500 μg intramuscularly, once per day. Both groups were treated for 3 co nsecutive weeks as one treatment course. Two courses later, hemorrheologic parameters, central retinal arterial and venous blood flow indexes were observed . Results: Comparison before and after treatment showed red blood cell aggregation index, the whole bloo d viscosity rate, plasma viscosity rate, fibrinogen and erythrocyte sedimentatio n rate, have all improved obviously (P<0.05, P<0.01). Compared wi th the control gro up, there was significant difference (P<0.05, P<0.01). With the treated group before and after treatment, the peak systolic velocity (P SV) of c entral retinal artery, their end diastolic volume, the acceleration, the central retinal venous reflux velocity have improved respectively. Nak ed eye visions were also improved, compared with the control group, the differe nce was significant (P<0.01). Conclusion: Puerarin could reduc e bl ood viscosity, improve microcirculation, and play a positive therapeutic role i n diabetic retinopathy.

Observation on efficacy of puerarin in treating diabetic retinopathy

Objective: Using the principle of promoting blood circulation to remove s tasis to observe central retinal arterial and venous blood flow indexes, and hemorrheology of diabetic retinopathy patients with puerarin. Methods: Thirty patients with diabetic retinopathy were randomly divided into the treated group (n=15) and the control group (n=15). The treated group was given puerarin 400 mg per day intravenously dripping. The control group was given Mikebao 500 μg intramuscularly, once per day. Both groups were treated for 3 co nsecutive weeks as one treatment course. Two courses later, hemorrheologic parameters, central retinal arterial and venous blood flow indexes were observed . Results: Comparison before and after treatment showed red blood cell aggregation index, the whole bloo d viscosity rate, plasma viscosity rate, fibrinogen and erythrocyte sedimentatio n rate, have all improved obviously (P<0.05, P<0.01). Compared wi th the control gro up, there was significant difference (P<0.05, P<0.01). With the treated group before and after treatment, the peak systolic velocity (P SV) of c entral retinal artery, their end diastolic volume, the acceleration, the central retinal venous reflux velocity have improved respectively. Nak ed eye visions were also improved, compared with the control group, the differe nce was significant (P<0.01). Conclusion: Puerarin could reduc e bl ood viscosity, improve microcirculation, and play a positive therapeutic role i n diabetic retinopathy.